Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1

Status

Completed 24Unknown 5Recruiting 5Withdrawn 4Terminated 4Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Sarcoma 1Head & Neck 1Dermatologic 1Breast 1

Conditions

Uveal Neoplasms 1Uveal Melanoma 1Thyroid Neoplasms 1Sarcoma, Ewing 1Neoplasm Metastasis 1Melanoma 1Iris Neoplasms 1Choroid Neoplasms 1Breast Neoplasms 1

Interventions

Radiotherapy 91pembrolizumab 88Cyclophosphamide 84Gemcitabine 70Cisplatin 70Magnetic Resonance Spectroscopy 65Carboplatin 60Radiosurgery 55Paclitaxel 55Nivolumab 48Dexamethasone 45Bevacizumab 42Biopsy 41Fluorouracil 39durvalumab 37Surveys and Questionnaires 36Docetaxel 36fludarabine 35Doxorubicin 35Radiation 33Oxaliplatin 33Capecitabine 33Rituximab 32fludarabine phosphate 31Leucovorin 31Cytarabine 30Melphalan 29Etoposide 28Pemetrexed 27Irinotecan 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Withdrawn × OTHER × Biopsy, Fine-Needle × Clear all
NCT05042934 2022-02-10

Lurbinectedin With or Without Irinotecan in Treating Patients With Relapsed or High Risk Metastatic Ewing Sarcoma

M.D. Anderson Cancer Center

Phase 1/2 Withdrawn
Sarcoma

Sarcoma, Ewing

NCT00329017 2019-10-10

Protocol for Postmenopausal Women at Increased Risk of Developing Breast Cancer

University of Kansas Medical Center

Withdrawn
Breast

Breast Neoplasms

NCT00406120 2018-06-26

Validation of a Molecular Prognostic Test for Eye Melanoma

Washington University School of Medicine

Withdrawn
Dermatologic

Uveal Melanoma, Choroid Neoplasms, Melanoma, Neoplasm Metastasis, Uveal Neoplasms, Iris Neoplasms

NCT00954837 2013-05-27

CYT2THYR

Assistance Publique - Hôpitaux de Paris

Phase NA Withdrawn
Head & Neck

Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡